Podcasts about healthcare technology

This episode was brought to you by Mouser, our go-to source for electronics parts for any hobby or prototype. Click HERE to discover how additive manufacturing is revolutionizing cornea transplants. Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

It's our monthly Digital Health Download, and September's stories all circle the same tension: technology keeps promising to fix healthcare's problems, but just as often it moves them somewhere else, or creates new ones entirely. This week, Halle unpacks a news-heavy month, weighing who actually benefits as markets, algorithms, and AI get closer to our health decisions.We cover:Americans can now bet on clinical trials and FDA regulatory reviews - but do we want that?Meta's massive settlement over harming childrenThe surprising reason AI might be making healthcare more expensive instead of lessA new study on the biggest lever we're not pulling to bend the healthcare cost curveTwo lawsuits rattling a popular wearable and a celebrity-backed mental health startupWhat a widely used drug class reveals about bias in hiring, and the uncomfortable questions that raises⸺

"I'd already finished my cardiovascular unit. I'd finished my pulmonary unit. I had never heard about this in any of my classes." That was Dr. Joel Bervell's reaction to discovering that a device used every day in hospitals -- the pulse oximeter -- reads less accurately on darker skin tones. He posted a 30-second video about this consequential discrepancy that, to his utter surprise, gained over 500,000 views by the next morning. That video launched Dr. Bervell into orbit as a social media presence and created his identity as The Medical Mythbuster. In just a few years, he's built a following of two million people, earned a Peabody Award and was named to the inaugural Time 100 Creators list, all while finishing his residency.  On this episode of Raise the Line, host Lindsey Smith welcomes Dr. Bervell to explore the roots of this kind of bias and the real world impact of drawing attention to it. “The most impactful biases in medicine exist because no one stops to ask who was included in the original data and who was left out,” Dr. Bervell explains. Stay tuned to also learn about: His YouTube animated series The Doctor is In which helps kids understand how their bodies work, as well as providing medical role models; How to build trust with marginalized communities; His forthcoming book, The Default Body which examines who medicine was actually designed for. Mentioned in this episode:Dr. Bervell on InstagramTikTok ChannelFacebook"The Doctor Is In" Show If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

We don't talk enough about how hard it actually is to build a healthcare startup. Behind SmarterDx's story, now one of the biggest health AI exits to date, were 18 months without a single customer, a pivot that seemed to make no product sense, and two co-founders who went back to working as hospitalists just to get by.In this episode, Steve gets the real story from Dr. Michael Gao and Dr. Joshua Geleris about the challenges they faced and what ultimately unlocked real growth and led to their billion+ acquisition by New Mountain Capital.We cover:Why their first product idea failed and what customer objections actually taught them to build insteadThe counterintuitive workflow that made contingency pricing possibleHow AI translation of clinical notes into billing codes now outperforms the average human, and what that means for coders and nursesWhy "moat" is the wrong metaphor and what a flywheel looks like insteadWhat they'd do differently in the acquisition processAbout our guests:Michael Gao, MD, the CEO and co-founder of SmarterDx. Prior to founding SmarterDx, Dr. Gao was the Medical Director for Transformation at NewYork-Presbyterian, where he led applied AI development, implementation, and strategy for the health system. Dr. Gao holds faculty positions at the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine. Dr. Gao completed his internship and residency in Internal Medicine at NewYork-Presbyterian.. He received his M.D. from the University of Michigan and a B.S from the University of California Los Angeles.Josh Geleris, MD, is the Head of Product and co-founder of SmarterDx. Prior to SmarterDx, he was Assistant Professor of Medicine at Columbia University, where he was funded by the National Institutes of Health and the Department of Defense for clinical informatics and data science, and led implementation of Epic for providers. Dr. Geleris completed his MD at the Technion-Israeli Institute of Technology and his Internal Medicine internship and residency at NewYork-Presbyterian. ⸺

Despite gains in recent years, Black, Hispanic, and Asian communities are still under-represented in the U.S. nursing workforce. We're going to explore that gap and how to close it on this episode of Raise the Line from Elsevier with Dr. Ernest Grant, Vice Dean for Diversity, Equity, Inclusion and Belonging at the Duke University School of Nursing. "You get a patient who is more compliant when they see someone who looks like them, who is from their culture and who can advocate on their behalf," he tells host Lindsey Smith.  Dr. Grant bases that and other insights on a rich professional background that includes 50 years in nursing, being a leading advocate for his profession and breaking down barriers himself as a male nurse of color and the first man elected president of the American Nurses Association.  In this thoughtful conversation, Dr. Grant reflects on what it took to earn credibility in leadership roles, how he's navigating the political climate on DEI initiatives, and the causes and solutions to the persistent shortage in nursing faculty, among other pressing issues. Tune in for a uniquely-informed look at what it will take to build a stronger, more representative nursing profession. Mentioned in this episode: Duke University School of Nursing American Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

It's back-to-school szn, and while some kids are stressing over earlier wake-ups, this year's incoming medical students have a bigger question to answer: how do you train for a career that could still have you practicing medicine in the 2070s, when the tools of medicine are changing so rapidly?For our back-to-school episode, we sat down with Stanford University School of Medicine Dean Dr. Lloyd Minor to talk about how AI is already reshaping what future doctors learn and how they're taught, as well as what's still not working in American healthcare.We cover:What medical students are actually being taught about AI, and where Stanford still draws the lineWhy Stanford's tumor boards no longer start with humansThe surprising way Dr. Minor thinks AI could level the playing field in healthcare accessWhy the same AI tools helping patients feel more informed are also making them more anxiousThe counterintuitive reason new medical technology gets more expensive before it gets cheaperWhat's still standing in the way of a vision for precision medicine that's been decades in the makingAbout our guest:Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.In 2012, Dr. Minor was elected to the National Academy of Medicine.—

What does it take to compete on the world's biggest stage and then pivot to one of the most demanding training paths in professional life? Today's guest, Samantha "Sammy" Kolowrat, has done both, and she has some fascinating insights into the commonalities of those two worlds on this episode of Raise the Line. “Something that really drew me to medicine is the team atmosphere that's there as you work towards a common goal, and there's this level of intensity that's very reminiscent of the experiences I had as a professional athlete.” Originally from Prague, Kolowrat represented Czechia at six IIHF Women's World Championships and the 2022 Beijing Olympics, and also captained the Division I women's hockey team at the University of Vermont while earning degrees in biology and pharmacology.  As she starts an anesthesiology residency at Vanderbilt University, she credits her athletic career with shaping how she handles pressure, feedback, and teamwork in medicine. "The more I improve, the more knowledge I acquire, the more skills I hone, the better care my patients get," she tells host Lindsey Smith, describing what drew her to a field that rewards the same relentless fine-tuning as elite sports. This engaging conversation also explores: How crippling performance anxiety as a Division I athlete ended up preparing Kolowrat for the operating room; Why she was drawn to anesthesiology's "well-oiled machine" atmosphere; The mentorship gap she's working to close for the next generation of athlete-physicians. Mentioned in this episode: Vanderbilt University Anesthesiology Residency Program If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

A missed delivery in a public health supply chain is never just a logistics problem. It can mean a child misses a vaccine, a patient goes without treatment, or an entire community loses trust in its healthcare system. In this episode of Supply Chain Now, Scott W. Luton welcomes Don Hicks, CEO of Optilogic, and Taylor Wilkerson, Executive Director of Design for Life, for a powerful conversation about using supply chain design to help more people access essential medicines. Don and Taylor explain why many public health supply chains face the same complexity as the world's largest commercial networks, but must operate with far fewer resources, limited infrastructure, and consequences measured in human lives rather than profit. Taylor shares how outdated systems, manual processes, and limited visibility can prevent medicine from reaching the communities that need it most, while Don explains why managing the existing network is not enough. Meaningful progress requires redesigning the system itself. The conversation explores why resilient supply chains must be built before a crisis hits. Taylor explains how better data, flexible networks, and stronger design can help healthcare systems respond to outbreaks and demand surges. He also shows how a single stockout can lead to missed care, greater health risks, and lost trust. The medicine may cost pennies. The real challenge is getting it to the right people at the right time. Don and Taylor also talk about how AI can make advanced supply chain tools more accessible. Local health leaders could ask questions in plain language, test scenarios, and make faster decisions without relying on outside consultants. By putting planning and optimization tools in the hands of the people closest to the problem, Design for Life aims to improve healthcare access and save lives. Jump into the conversation: (00:00) Intro (02:31) Meet Don Hicks and Taylor Wilkerson (07:25) Taylor's path into public health supply chains (09:27) Don's experience with global healthcare delivery (13:06) The mission behind Design for Life (17:57) Why resilient supply chains must come before crisis (20:04) How public healthcare networks really operate (22:02) Why managing the current system is not enough (24:23) Turning supply chain studies into action (27:48) Two forces reshaping global health supply chains (30:17) How AI can democratize supply chain design (33:15) The human cost of medicine stockouts (37:46) Making advanced planning tools easier to use (40:38) Why the best user interface may be none (44:40) Empowering local experts to make decisions (48:42) How to support Design for Life (51:13) Finding purpose through supply chain work Additional Links & Resources: Connect with Taylor Wilkerson: https://www.linkedin.com/in/taylor-wilkerson-21477a/ Learn more about Design for Life: https://designforlife.org/ Connect with Don Hicks: https://www.linkedin.com/in/donald-hicks-35575b/ Learn more about Optilogic: https://optilogic.com/ Learn more about our hosts: https://supplychainnow.com/about Learn more about Supply Chain Now: https://supplychainnow.com Watch and listen to more Supply Chain Now episodes here: https://supplychainnow.com/program/supply-chain-now Subscribe to Supply Chain Now on your favorite platform: https://supplychainnow.com/join Work with us! Download Supply Chain Now's NEW Media Kit: https://supplychainnow.com/media-kit/ WEBINAR- From Volume to Resilience: How Automotive Supply Chains Are Adapting to a New Market Reality: https://bit.ly/4f6SUGA WEBINAR- From Disruption to Stability: Building Resilient Logistics Solutions in a Rapidly Changing Global Market: https://bit.ly/3TguZMt WEBINAR- SAP AI Inside the Supply Chain: From Silo to Orchestration: https://bit.ly/4bvpz6K This episode was hosted by Scott Luton and produced by Trisha Cordes, Joshua Miranda, and Amanda Luton. For additional information, please visit our dedicated show page at: https://supplychainnow.com/public-health-supply-chain-redesign-bigger-band-aids-will-not-work-1621 The content in this episode, including all audio, videos, visuals, and graphics, is the property of Supply Chain Now and is protected by copyright law. Unauthorized use, reproduction, distribution, modification, or re-uploading of this content in any form is strictly prohibited without explicit written permission from Supply Chain Now.For licensing inquiries or permissions, please contact us at production@supplychainnow.com© 2026 Supply Chain Now. All rights reserved. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We're on summer break and replaying one of our favorite episodes. This episode originally aired on September 22, 2025.A wearable can collect endless data, but it only matters if people trust it enough to change their behavior.In this replay, Oura CEO Tom Hale joins Steve and Michael to explain how the company combines clinical-grade accuracy with a consumer-friendly product. They discuss why the ring's form factor makes overnight tracking so powerful, how Oura turns physiological signals into useful guidance, and why the company is being pulled faster than expected into traditional healthcare.We cover:Why sleep data can reveal changes in the body before symptoms appearHow Oura designed a health product that supports users without judging or nagging themWhy accuracy is the foundation for trust, predictions, and behavior changeHow Oura navigates the boundary between wellness products and regulated medical devicesThe company's expansion into Medicare Advantage, women's health, metabolic health, and clinical care—About our guest:Tom Hale is the Chief Executive Officer at ŌURA and a member of its board. As the CEO he sets the company's business strategy and vision to make health a daily practice for members all over the world. He has over 30 years of experience across the technology and consumer product industry.Before joining ŌURA, Hale was president of Momentive where he drove B2B strategy and led product growth. During his time there he was instrumental in taking the company public in 2018, leading the team in key acquisitions, and driving the evolution and rebranding of the company into a multiple SAAS business. Previously, he held leadership roles at HomeAway and Linden Lab as the Chief Operating Officer and Chief Product Officer, respectively, and held executive roles at Macromedia and Adobe.Hale has a Bachelor of Arts from Harvard University and sits on the boards of Cars.com, RocketReach, and NoiseAware.—If you're enjoying the show, we would so appreciate it if you left us a review!—

Most nursing home administrators don't realize they're sitting on one of the most underutilized revenue streams in all of Medicare — and until someone shows up and tells them what it's worth, they never will. In this episode, Scott Middleton — founder and Chief Disruption Officer of Your Health — calls in from the road as he travels across rural Georgia on a multi-day facility tour, fresh off completing a major merger with TCPA. What follows is an unfiltered, on-the-ground breakdown of two transformational opportunities Scott is actively building: chronic care management (CCM) reimbursement and ACO cost savings — and the very specific reasons most of the industry is getting both wrong. In this episode, you'll hear: Why Medicare already pays $65/hour for care management performed by nurses, community health workers, and social workers — and how Your Health is now contracting with nursing home facilities to perform it, paying them up to $100 per patient per month The "Fuse" platform — a communication and documentation tool that routes care management notes directly into billing-ready buckets, syncing with point-of-care software so the minutes get captured and billed automatically How ACO risk scores work, why Your Health's scores have grown 30% under their current plan, and what failing to see hospice patients could cost the organization — up to $22 million in a single year The $4,800 per patient per year problem: how one physician in their network was quietly rated one of the worst under the ACO model simply because his patients were going home without any follow-up Scott's announcement that SSAs and TCPs are being restructured to report directly to peer group administrators — and why the confusion about their roles has cost the company If you lead a nursing home, an assisted living facility, a physician group, or any organization inside the long-term care ecosystem, this episode will change how you look at what you're already doing — and what you're leaving behind. www.YourHealth.Org

An 11-year-old boy in rural Zambia once told Dr. Genesis Mwamba that he was about to attend school wearing shoes for the first time in his life. That moment, Dr. Mwamba says, crystallized why he started the Lead Me Back Foundation to provide school supplies and other support to marginalized communities in his native country.   As you'll learn in this inspiring installment in our NextGen Journeys series, Dr. Mwamba started the foundation in 2021while still a medical student because he had experienced the power of education as an “equalizer” in his own life, taking him from humble roots to a career in medicine. He and his colleagues have grown the bootstrapped organization to a point where it now provides hundreds of thousands of people across the country with educational access, climate education and community health clinics. “I've always been drawn to opportunities and initiatives that bring help to humankind,” he tells Raise the Line host Dr. Parsa Mohri. This episode also explores: What building "with" a community rather than "for" it looks like in practice; The storytelling strategy that attracted donors and partners; How his mother's untimely death inspired his commitment to preventive medicine.   Mentioned in this episode: Lead Me Back Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This month is about the gap between what a system offers and what people actually get from it: drugs that work better with support nobody's paying for, AI that's already answering more medical questions than most doctors ever will, and a labor market where staying healthy can mean staying stuck. Halle and Michael break down the stories reshaping digital health in August.We cover:Why GLP-1 funding is shifting from prescribing platforms into "companion" ecosystemsThe FDA panel vote that opens a legal pathway for six unapproved peptides, and what this could meanOur thoughts on OpenAI's new ChatGPT Health product, now available to every US adultThe Florida pastor's lawsuit against OpenAIWhy nearly one in four US workers are staying in jobs they'd rather leave, just to keep their health insuranceThe healthcare argument buried inside the bill to make daylight saving time permanentLinks:Rock Health, H1 2026 digital health funding recapHalle's research piece, Virtual GLP-1 startups: Pill mills or the future of obesity care?RAPS, FDA advisory committee backs six peptides for compounding listTechCrunch, OpenAI makes ChatGPT Health available to all US usersCBS News, ChatGPT's medical advice nearly killed a Florida man, lawsuit claimsGallup, One in four US employees locked in jobs for health insuranceThe Hill, House passes Sunshine Protection Act—

"We have an untapped army of 200,000 PAs that really could step up and drive some change in the healthcare system if we weren't restricted,” says Dr. Jennifer Kolb, capturing her motivation for pushing to update practice regulations for physician associates that date back more than 50 years.  As Chief Medical Officer and Senior Vice President of Clinical Affairs at the American Academy of Physician Associates, Dr. Kolb has been in the middle of the fight at the state and federal level to grant PAs more independence from physicians, full billing rights, and the increased ability to practice across state lines, among other changes.  In this pertinent conversation with Raise the Line host Lindsey Smith, Dr. Kolb explains how these updates could help close huge gaps in access to healthcare, better manage the fight against chronic diseases and improve patient outcomes.   Dr. Kolb also addresses:  Why the name shift from "assistant" to "associate" took her years to fully appreciate; How a 10-year gap in life expectancy across Chicago zip codes shapes her view of health equity; Why PA's shouldn't wait for permission to start making change in their communities. Mentioned in this episode:American Academy of Physician Associates   If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Send us a MessageIn this episode of Culture Change RX, Sue welcomes Mark Allen, founder of Rural Health Engine, for a conversation about innovation, technology, and the future of rural healthcare.Mark shares how his journey—from growing up in rural Missouri, to serving in the U.S. Coast Guard, to helping innovative technology companies—ultimately led him to create Rural Health Engine, a nonprofit dedicated to connecting rural hospitals with practical, affordable innovations.Rather than selling products, Mark sees his role as helping rural healthcare leaders discover what's already available and determine which innovations truly fit their organization's needs.The conversation explores why innovation isn't just about adopting artificial intelligence or new software. It's about asking better questions, thinking differently, and recognizing that doing nothing may be the greatest risk of all.To learn more about Rural Health Engine, complete the Innovation Readiness Assessment, or connect with Mark Allen:Website: Rural Health EngineEmail: allen@ruralhealthengine.org[FREE Webinar] A 5-Step Approach to Achieving Nursing Excellence in Rural Hospitals:  Aug 11 at Noon ETMany rural hospitals need a proven approach for creating and sustaining nursing excellence. Join Capstone for a special 1-hour webinar where we will overview our proven 5-step approach for achieving nursing care improvements that take hold and last.Register here: https://capstoneleadership-net.zoom.us/meeting/register/gCRrqIc2QeK7mj-1gzIJsgHi! I'm Sue Tetzlaff. I'm a culture and execution strategist for small and rural healthcare organizations - helping them to be the provider and employer-of-choice so they can keep care local and margins strong.For decades, I've worked with healthcare organizations to navigate the people-side of healthcare, the part that can make or break your results. What I've learned is this: culture is not a soft thing. It's the hardest thing, and it determines everything.When you're ready to take your culture to the next level, here are three ways I can help you:1. Listen to the Culture Change RX PodcastEvery week, I share conversations with leaders who are transforming healthcare workplaces and strategies for keeping teams engaged, patients loyal, and margins healthy. 2. Subscribe to our Email NewsletterGet practical tips, frameworks, and leadership tools delivered right to your inbox—plus exclusive content you won't find on the podcast.

Every day, roughly 100 Americans die in crashes caused by human drivers. Yet when a self-driving car hesitates at an intersection or makes the news for an unusual mistake, public trust can evaporate.In this special episode, Dr. Jonathan Slotkin reads his latest Noema essay exploring why we demand perfection from machines while accepting human error as inevitable. Drawing on lessons from medicine, psychology, and autonomous vehicles, he argues that the biggest barrier to safer technology is trust.You'll learn:Why humans judge machine mistakes differently than human mistakesWhat healthcare learned about the difference between being safe and feeling safeWhy autonomous vehicles may already be far safer than human driversHow public perception can slow the adoption of life-saving technologyWhat every AI company should learn about transparency and trust —About our guest:Dr. Jonathan Slotkin is Chief Medical Officer for Strategy & Growth at Geisinger, where he drives growth at the intersection of care delivery, insurance, and digital transformation. A practicing neurosurgeon, he previously served as Geisinger's associate chief medical informatics officer.Jon's current research and writing examine safety, trust, and adoption of autonomous systems in public life. His New York Times guest essay on self-driving car safety was entered into the Congressional Record. His writing regularly appears in Harvard Business Review, STAT, and Noema Magazine. He has authored more than 70 peer-reviewed scientific publications.Previously, as co-founder and chief medical officer of Contigo Health, he partnered with the nation's largest employers to reimagine care for their associates. He co-founded Scrub Capital, a clinician-powered venture capital firm, where he serves as a Partner. He completed neurosurgery residency at The Brigham and Women's Hospital, Harvard Medical School, where he served as chief resident.—This piece was commissioned, edited, and published by Noema Magazine. Noema publishes longform journalism exploring fresh ideas. To read this piece and others, head to noemamag.com.—

Hey there Voices of the Bench community, this is Trish Jones with Ivoclar. If you've been curious about fast-firing zirconia to improve efficiency but aren't convinced it can deliver predictable, high-quality results, I'd encourage you to connect with us. Our new IPS Emax Zirconia offers multiple fast-fire protocols designed to help save you valuable production time while maintaining consistent results. Time is money in every lab. Don't wait. Reach out to your local Ivoclar rep today and discover how IPS Emax Zirconia can help streamline your workflow. As full-arch dentistry continues to grow, so do the demands on today's dental laboratories. That's why Knight Dental recently launched SimplyARCH Studio, a dedicated production environment built exclusively for full-arch restorations. To support this specialized workflow, Knight invested in an XTCERA milling system and carefully evaluated multiple CAM software solutions before choosing hyperDENT. The decision came down to exceptional milling quality, minimal hand finishing, and impressive production efficiency. But what truly set hyperDENT apart was the implementation process. From the very beginning, the team provided more than software training—they shared the knowledge and experience needed to build an optimized workflow for complex full-arch cases. With proven expertise in advanced milling strategies and laboratory production, hyperDENT helped ensure SimplyARCH Studio was designed for long-term success from day one.Matt Everatt joins Elvis and Barb for a fascinating conversation that takes a deep dive into his journey through the dental laboratory industry and the story behind his book, The Invisible Profession. From discovering dental technology at 16 and specializing in maxillofacial prosthetics and orthodontics to working in hospitals, developing early sleep-apnea appliances, and nearly leaving the profession altogether, Matt's career has taken some seriously interesting turns. Eventually, he helped co-found S4S, building a successful business around sleep-apnea appliances, occlusal splints, orthodontics, and more before eventually stepping away from ownership. Matt Everatt joins Elvis and Barb for a fascinating conversation that takes a deep dive into his journey through the dental laboratory industry and the story behind his book, The Invisible Profession. From discovering dental technology at 16 and specializing in maxillofacial prosthetics and orthodontics to working in hospitals, developing early sleep-apnea appliances, and nearly leaving the profession altogether, Matt's career has taken some seriously interesting turns. Eventually, he helped co-found S4S, building a successful business around sleep-apnea appliances, occlusal splints, orthodontics, and more before eventually stepping away from ownership. But this conversation goes far beyond Matt's career. His book, The Invisible Profession, explores how the dental laboratory industry arrived at a place where technicians and laboratories are often undervalued, pushed into price competition, and expected to simply keep their heads down and produce. Matt shares his thoughts on the "million little things" that shaped the industry, the danger of becoming a "busy fool," and why laboratories need to stop competing solely on price and start becoming known for the value, expertise, and partnership they bring to the dental team. Elvis, Barb, and Matt also talk about the changing landscape of digital dentistry, AI, 3D printing, speed, service, and why the labs that embrace change and remain agile will be the ones positioned for the future. It's an honest, thought-provoking, and ultimately optimistic conversation about where the dental laboratory profession has been, where it is today, and where it can go next.Special Guest: Matt Everatt.

Most adults who smoke want to quit, and about half try to do so in any given year, yet fewer than one in ten succeed. That persistent gap between intention and outcome is one of the central challenges in public health, and it's exactly the kind of problem that calls for new thinking about how to communicate with people to support behavior change.  Dr. Amanda Graham has been a leading force in doing just that in her role as chief health officer at Truth Initiative, the nation's largest non-profit public health organization dedicated to preventing addiction among young people and helping people of all ages to quit tobacco. On this episode of Raise the Line from Elsevier, Dr. Graham, who holds a PhD in clinical health psychology and has done 25 years of NIH-funded research focused on technology-based cessation interventions, helps us understand the interplay between behavioral science and digital communications in the field. "A well-timed message can really be powerful in interrupting what for many people is kind of an automatic behavior, especially via text, which data tell us is an extraordinarily powerful modality,” she explains to host Lindsey Smith.  Tune-in to understand where the field is heading, and to learn about: Why "push" technology may work better than apps and websites when it comes to breaking automatic behaviors; How the rise of e-cigarettes, nicotine pouches, and heated tobacco has scrambled decades of public health messaging; How highschool smoking rates plunged from over 30% to less than 2%. Mentioned in this episode: Truth Initiative Program with Mayo Clinic If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Healthcare companies are built to improve patients' lives. So why do so many prioritize shareholders over the people they're meant to serve?This week, Halle sits down with Eric Ries, author of Incorruptible, to unpack the rise of shareholder primacy, what it is, and why he believes it's at the root of many of society's biggest challenges. They discuss the surprising history of corporate governance, the lessons behind Novo Nordisk's century-long success, and what founders can do today to keep their companies aligned with their mission as they grow.We cover:Why shareholder primacy reshaped corporate America (and where we go from here)How Novo Nordisk's unusual ownership structure may have saved GLP-1 researchThe simple governance change that could preserve your company's mission for decadesHow boards, investors, and acquisitions can slowly pull companies away from their original purposeThe founder mistakes that make mission drift almost inevitableAbout our guest:Over the last two decades, Eric Ries's ideas about continuous innovation, long-term thinking, governance, and market reform have reshaped company building and management practices. He is the creator of the Lean Startup method, and the author of two New York Times bestsellers The Lean Startup and Incorruptible; The Leader's Guide; and The Startup Way. As a founder, he has put his own ideas into practice with The Long-Term Stock Exchange (LTSE); Answer.AI, an AI R&D lab; Virgil, a legal services startup; and IMVU. On The Eric Ries Show, he talks with world-class technologists, thought leaders, and executives building for the long-term. Check out his book, Incorruptible: Why Good Companies Go Bad…and How Great Companies Stay Great—

"I always remember feeling like I was part of the clean plate club," says Dr. Christle Guevarra, recalling a childhood spent quietly convinced that her weight was a matter of willpower. That belief followed her through a competitive powerlifting career and medical practice until she finally tried a GLP-1 medication herself and, as she describes it, the constant mental noise around food quieted down. Now a board-certified family and sports medicine physician, traveling team doctor for U.S. Figure Skating, and author of The Beginner's Guide to GLP-1s, Dr. Guevarra brings a rare combination of clinical authority and lived experience to the conversation around obesity medicine.  In this episode of Raise the Line from Elsevier, host Lindsey Smith talks with her about what's actually changed in how physicians understand the issue and what it means for patients. "The biggest thing is reframing how we approach weight loss. It's not just a willpower problem, it is a neurobiological problem." Tune in to learn about: Why she said no to a GLP-1 prescription for two years and what finally changed her mind; The real story behind concerns about muscle loss on these medications; What happens when the “food noise" goes silent and a new set of challenges takes its place.   Mentioned in this episode:  Dr. Christle's website If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Stroke is one of the leading causes of disability in Canada—and for survivors in rural and remote communities, recovery often means navigating a health-care system with far fewer resources than their urban counterparts. In this episode of From Here Forward, hosts Carol Eugene Park and Jeevan Sangha sit down with Dr. Brodie Sakakibara, associate professor in UBC's Department of Occupational Science and Occupational Therapy and director of the Okanagan Stroke Research Lab, to unpack how telehealth and virtual rehabilitation are reshaping recovery across BC's Interior.Dr. Sakakibara breaks down why the current health-care system's acute-care focus leaves many stroke survivors without support once they return home—and how that gap contributes to alarming numbers: 16% of stroke survivors will have a second stroke within a year, and one-third within five years. He shares how his lab is using technology to extend care into rural communities, empower patients to self-manage chronic health, and address barriers like device and internet access.Listeners will also learn how to recognize stroke symptoms, the modifiable risk factors that matter most for prevention, and why sleep, stress management, and physical activity remain foundational to long-term recovery. Links & Resources Mentioned in This Episode:Contact CarolContact JeevanFrom Here ForwardPodium Podcast CompanyAbout Brodie SakakibaraLearn more about the StrOKe LabKnow FAST - the signs of stroke (00:00) - Introduction (01:33) - Meet Dr. Brodie Sakakibara (01:58) - Stroke recovery research + long-term health (02:56) - From clinical path to research career (05:02) - The Okanagan Stroke Research Lab (05:42) - Stroke recovery after discharge (07:24) - Telehealth, telerehab + COVID's impact (09:06) - Rural access + health equity (12:36) - Stroke risk factors + secondary prevention (14:10) - Younger strokes + prevention gaps (16:06) - Extending stroke care into the community (16:58) - Stroke stats everyone should know (18:17) - Stroke awareness + FAST signs (19:22) - Daily habits for stroke prevention (20:42) - Conclusion

Over the last decade, the number of drug candidates entering development has doubled, yet the number of successful drug approvals remains flat at ~50 per year.This week, we sit down with Formation Bio founder and CEO Ben Liu. His company has raised more than $600 million to build what he hopes will become the first new enduring pharmaceutical company in decades, powered by AI. Ben explains why he believes clinical development, not drug discovery, is becoming the industry's biggest bottleneck, and how AI could fundamentally change the economics of bringing new medicines to patients.We cover:Why there hasn't there been a big pharma company created since the 1980sWhich drug categories Ben believes could become the next GLP-1s and reshape healthcareWhy Formation Bio chose to become a pharmaceutical company instead of selling softwareThe real bottleneck in bringing medicines to patientsBen's roadmap for how AI will transform drug development over the next 10 to 20 yearsAbout our guest:Ben Liu is the co-founder and CEO of Formation Bio. He received his DPhil at Oxford as a Rhodes Scholar, leveraging machine-learning, AI, and big-data to develop diagnostics and therapeutics for Parkinson's and Alzheimer's disease. During his graduate work, he observed the way clinical trials bottlenecked the development of new treatments for patients, compelling him to start Formation Bio.Before Formation Bio, Ben graduated from Yale where he was awarded the college's highest honor at graduation and received his MPhil with distinction in Computational Biology from the Department of Applied Mathematics and Theoretical Physics at Cambridge as a Paul Mellon Fellow. Ben also serves as an Advisor to Harvard Business School's MS/MBA Program in Biotechnology.—

The American healthcare system is built around a simple idea: get sick, get treated. But what if the problem isn't how we treat illness — it's that we've never seriously tried to prevent it? In this first installment of a two-part conversation, Jamie sits down with Brody Wall, Division President of Operations at Your Health, to trace the arc from a broken, reactive healthcare system to one where data tells you what's coming before the patient even knows something is wrong. Brody's path to healthcare wasn't through a textbook — it was through a father who was a Methodist minister and a mother who spent her career caring for underprivileged children. The mission was always there. The data just became the most honest way to fulfill it. In Part 1, Jamie and Brody cover: Why fee-for-service healthcare financially rewards volume of sick visits — not health — and how that one incentive structure explains why 17-20% of America's GDP goes to healthcare costs with outcomes that still lag behind other developed nations What Your Health was flying blind on before it committed to building a real data infrastructure — and what gut-feeling decisions look like when data finally proves them wrong How social determinants of health (Z codes) and behavioral health conditions (F codes) reveal which patients are actually at the highest risk of hospitalization The finding that changed everything: patients with four or more behavioral health conditions were ten times more likely to have multiple ER visits — and the clinical response that followed This isn't just a conversation about numbers. It's about what happens when an organization decides that preventing the crisis matters more than reacting to it. Part 2 drops next week. www.YourHealth.Org

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

Millions of Americans were saddened and outraged by the Sandy Hook Elementary shooting in 2012 that took the lives of twenty children and six adults, and were left feeling helpless about the epidemic of gun violence in the U.S. that, sadly, continues to this day. But for our guest today, Shannon Watts, her feelings of devastation about the shooting turned to rage and fueled her unlikely rise to leading Moms Demand Action, which she grew into one of the largest grassroots organizations in the country, mobilizing millions of volunteers to push for stronger gun safety laws. “I wanted to stand shoulder to shoulder with a badass army of women because that's who gets things done in this country,” she says.    In this inspiring conversation with Raise the Line host Michael Carrese, Watts pulls back the curtain on how the group achieved its successes and the philosophy of "losing forward" that kept volunteers showing up year after year. In her recent book Fired Up, Watts describes how she is bringing insights from that experience to a new mission: helping women identify their values, abilities, and desires and acting on them without waiting until everything is perfect. Tune-in to learn about:  The "false fires" women mistake for passion; Why losing estrogen and testosterone in midlife might actually make women braver, not less so; The one exercise she does with every woman she coaches.  Mentioned in this episode: Fired Up book Moms Demand Action If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

Healthcare supply chain technology is evolving rapidly, but systemic data fragmentation and operational inefficiencies are moving even faster.    In this episode of Supply Chain Now, Scott W. Luton and Scott DeGroot are joined by Mark Holmes of InterSystems and Michael LaRocca of Ready Computing to discuss the shift from legacy networks to proactive, AI-driven decision intelligence.     The panel explores the severe consequences of a 10% global surgery cancellation rate due to supply failures, noting that a single canceled orthopedic procedure can cost up to $250,000, while the human toll can be tragic. They address how a lack of visibility leads to duplicate data entry and supply hoarding, outlining a blueprint for a smart data fabric. By leveraging real-time telemetry and agentic AI, healthcare organizations can automate inventory replenishment and resolve disruptions before they impact care. Scott DeGroot concludes by challenging healthcare leaders to audit their tech stacks and bridge the gap between clinical and supply chain data.   Jump into the conversation: (00:00) Intro  (02:12) Meet InterSystems and Ready Computing leaders  (08:28) Ready Computing's 15-year history of system connection  (10:43) InterSystems' 48 years of mission-critical data tech  (12:29) The life-or-death stakes of healthcare supply chains  (17:29) Global surgery cancellations inflict severe financial penalties  (21:13) Interoperability standards stitch disconnected databases together  (24:43) The "swivel-chair effect" and supply chain hoarding  (30:40) Supply Chain Orchestrator powers proactive data orchestration  (34:45) Channels360 unifies case management and logistics workflows  (40:11) Practical applications of RAG and agentic AI  (55:16) Expanding rural healthcare infrastructure strains traditional supply lines   Additional Links & Resources: Connect with Mark Holmes: https://www.linkedin.com/in/mark-s-holmes/ Connect with Michael LaRocca: https://www.linkedin.com/in/mlaroccaready Connect with Scott DeGroot: https://www.linkedin.com/in/scott-degroot-4600368/ Learn more about InterSystems: http://www.intersystems.com Learn more about Ready Computing: https://readycomputing.com/ Learn more about our hosts: https://supplychainnow.com/about Learn more about Supply Chain Now: https://supplychainnow.com Watch and listen to more Supply Chain Now episodes here: https://supplychainnow.com/program/supply-chain-now Subscribe to Supply Chain Now on your favorite platform: https://supplychainnow.com/join Work with us! Download Supply Chain Now's NEW Media Kit: https://supplychainnow.com/media-kit/ WEBINAR- Peak Reality Check: What Shippers, Analysts, and AI Models Are Predicting for 2026: https://bit.ly/4aTlsRv WEBINAR- The Future of Supply Chains: Where Talent Meets Technology: https://bit.ly/4uUuxkc WEBINAR- From Volume to Resilience: How Automotive Supply Chains Are Adapting to a New Market Reality: https://bit.ly/4f6SUGA   This episode was hosted by Scott Luton and Scott DeGroot and produced by Trisha Cordes, Joshua Miranda, and Amanda Luton. For additional information, please visit our dedicated show page at: https://supplychainnow.com/how-readiness-drives-better-patient-outcomes-1605 The content in this episode, including all audio, videos, visuals, and graphics, is the property of Supply Chain Now and is protected by copyright law. Unauthorized use, reproduction, distribution, modification, or re-uploading of this content in any form is strictly prohibited without explicit written permission from Supply Chain Now.For licensing inquiries or permissions, please contact us at production@supplychainnow.com© 2026 Supply Chain Now. All rights reserved. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

They built a $1.2 billion healthcare AI company in under three years, but they say the hardest part of healthcare AI isn't the AI.This week, Halle sits down with Assort Health co-founders and co-CEOs Jeffery Liu and Jon Wang, whose company reached a $1.2 billion valuation in under three years. They discuss why building great healthcare AI takes far more than good models, how they scaled from 15 employees to nearly 250 in a year, and what they've learned from more than 190 million patient interactions. They also share why voice AI is harder than it looks, how they're thinking about building durable moats in the age of foundation models, and why helping patients navigate the healthcare system may be one of AI's biggest opportunities.We cover:The AI role suddenly showing up at every healthcare startupThe surprising demographic that gives AI voice agents the highest satisfaction scoresHow healthcare AI is shifting from single-purpose tools to platforms that remember patients across every interactionWhy the biggest moat in healthcare AI may not be the model itselfThe biggest misconception investors have about moats in healthcare AIHow to triple your team without losing the culture that made the company successful—

Most companies recruit interns to take work off someone's plate. Your Health does the opposite — and it's why several of its current executives, including a Chief Information Officer, first walked in the door as interns. In this episode, Jamie sits down with Heather Bower, Director of Experiential Learning, who has taken the reins of Your Health's internship, mentorship, preceptorship, and apprenticeship programs. Heather shares how a long-standing program is being rebuilt with structure, data, and intention — organized into semester cohorts, anchored by a four-day all-company orientation, and designed so every intern owns a project with genuine stakes. In this conversation, you'll hear: Why "get interns because they're cheap" is exactly the wrong spirit — and what replaces it How one MBA intern's shadowing experience redirected him toward nursing school The "spreadsheet whisperer" intern who taught regional leadership to pull data faster What surprises interns most once they're inside healthcare: the human complexity How Your Health uses feedback loops to move interns toward roles where they'll actually shine If you're early in your career and unsure where you fit, this episode is a map to possibilities you may not know exist. Press play and rethink what an internship can really be. www.YourHealth.Org

In the United States, nearly 70% of people say they want to die at home, yet the majority still die in medical settings, often after receiving care that may not match their goals and values. Closing that gap between preference and reality is at the heart of the work being done by End Well, a nonprofit dedicated to transforming how we think about, plan for, and experience the end of life. "The gap isn't about people wanting the wrong things. It's that our culture and our incentives aren't aligned with helping those wishes actually happen at the end of life,” says Dr. Shoshana Ungerleider, End Well's founder and president.  As Dr. Ungerleider explains to Raise the Line host Michael Carrese, End Well sponsors an annual symposium and year-round activities to bring together clinicians, patients, caregivers, and innovators to improve that alignment. Key steps include earlier integration of palliative care, allowing providers time for listening and goal setting with patients, and normalizing conversations about what matters most to people. This compelling conversation on reframing end of life care also covers how to bring wonder, joy, and hope into end-of-life conversations, and End Well's work to change how death is portrayed in the media. Mentioned in this episode:End Well If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Andrew Archibald, CEO of MEDMIN, breaks down why the UK's private healthcare sector has been stuck in operational chaos — and what he's doing to fix it. Built on a model where NHS consultants moonlight as private practitioners with zero business infrastructure, the system has forced brilliant surgeons to spend Sunday mornings writing their own invoices. MEDMIN steps in as a total practice management partner, handling admin, billing, marketing, and patient relations so doctors can focus on medicine. The results speak for themselves: new-to-practice consultants see 300% income growth within three years. Andrew also makes the case for embracing AI tools as a non-negotiable business move, and shares how MEDMIN is scaling toward a UK-wide brand that serves both doctors and patients. Key Takeaways: 3:34 — Curiosity is a professional strategy: Andrew attributes his entire career trajectory to a compulsion to understand how systems work and why they break, which drives him toward roles others avoid. 6:08 — COVID exposed a healthcare system already running on empty: the UK's waiting lists doubled during the pandemic and have never fully recovered because the NHS was underfunded through the 2010s before the crisis hit. 15:17 — The problem is personal: top-tier surgeons are spending Sunday mornings reconciling invoices instead of recovering, and that hidden administrative tax is the core inefficiency MEDMIN was built to eliminate. 24:42 — The ROI of removing friction is measurable: consultants who join MEDMIN as new-to-practice doctors grow their earnings by 300% between year one and year three. Quote of the Show (19:21):"People have just learnt to put up with inadequate systems. The healthcare system in the UK is very poor at investing in technology, in the administrative things that make the whole thing get better. And it's about time to say: stop accepting it." — Andrew Archibald Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Andrew Archibald:LinkedIn: http://www.linkedin.com/in/andrew-archibald-363050aCompany Website: https://medmin.co.uk How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlD YouTube: https://www.youtube.com/results?search_query=disruption+%2F+interuuptionSee omnystudio.com/listener for privacy information.

July marks five years of The Heart of Healthcare, and we're grateful for every listener who's tuned in. If you've enjoyed the show, please show your love by leaving us a review!This month, Steve and Halle take stock of an industry where capital is concentrating, incumbents are making big bets, AI is moving from promise to early proof points, and a public health crisis is quietly building in the background.We cover:The digital health funding numbers that just dropped, and what they reveal about where the money is really goingA $12 billion deal that has the RCM world buzzingThe Nature study that has clinical AI companies on edgeA new entrant into medical imaging that nobody saw comingThe public health crisis that sports betting built, and why healthcare isn't talking about it enoughEarly data out of Utah that could change how we think about AI in clinical settingsLinks:IPO Watch List: https://halletecco.substack.com/p/the-digital-health-ipo-watchlistEnsemble Health / Thoreau deal: https://hitconsultant.net/2026/06/18/thoreau-makes-strategic-investment-in-ensemble-health/Nature Medicine AI study: https://www.nature.com/articles/s41591-026-04431-5Midjourney Medical: https://www.theverge.com/ai-artificial-intelligence/952011/midjourney-medical-ai-ultrasound-scanDoctronic pilot outcomes: https://commerce.utah.gov/wp-content/uploads/2026/05/Doctronic-Outcomes-May-2026.pdf—

While Elsevier's most recent Clinician of the Future Report shows increasing adoption of artificial intelligence tools among physicians and nurses, and optimism that they will improve quality of care in the future, a majority raised concerns about trust and reliability. To increase the level of trust, 60% said transparent citations of evidence-based and peer-reviewed research will be key. How to provide that transparency is our focus today as Raise the Line host Lindsey Smith welcomes Elsevier colleagues Rhett Alden and Raman Kaur to guide us through the complexities involved, including the concept of traceability and what role it plays in how AI tools such as Elsevier's ClinicalKey AI are built and deployed.  “Traceability changes the confidence that a clinician has in an AI tool so that they aren't trusting the AI, they're trusting the underlying evidence they're consuming from the AI-assisted platform,” says Raman, who brings years of experience as a primary care practitioner to her work.  It's also important, Rhett adds, to provide additional information, pulled from both the clinician's query and the patient's medical record, to inform clinical thinking. “ClinicalKey AI can be more than a response engine by establishing a larger context to provide a more precise answer for that individual patient.” In this thought-provoking discussion, these experts also provide insights on: Mitigating bias in AI results; Using AI responsibly with sustainability in mind; What type of clinician will benefit most from AI Mentioned in this episode: ClinicalKey AI Clinician of the Future Report If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Back by popular demand, 3x Heart of Healthcare guest Eric Larsen joins Steve to answer listener questions on healthcare's AI revolution. Drawing on the ideas behind his latest essay, Healthcare's Oppenheimer Moment, Eric argues that healthcare may be approaching a once-in-a-generation inflection point, and discusses what leaders need to understand before it's too late.We cover:Whether foundation models will eventually outperform healthcare-specific AI companiesWhy healthcare remains stuck in AI pilot projects while the technology races aheadThe biggest obstacle to clinical AI adoptionWhy liability may be the most important (and least discussed) issue in healthcare AIEric's controversial take on how AI will reshape the healthcare workforce—Links:Eric's essay is available here —

It's been one year since the U.S. Centers for Disease Control and Prevention, in an unprecedented move, dismissed all the members of its Advisory Committee on Immunization Practices (ACIP), kicking off what would turn out to be a very concerning and busy year for infectious disease specialists.  We're going to recap this turbulent period – which includes a resurgence of measles, an unusually rough flu season, the emergence of a new COVID strain and outbreaks of hantavirus and Ebola – with Dr. William Schaffner, one of the country's most frequently quoted medical experts on infectious disease, vaccination, and public health. As a member of ACIP for decades, Dr. Schaffner brings unique insight into the dismantling of the committee and the distrust of vaccines that lies at the root of the changes. As he explains to Raise the Line host Lindsey Smith, while many vaccine critics are beyond reach, there are those he describes as vaccine hesitant that may be persuadable if the right approach is taken. “Beyond providing facts, we have to listen to them and respond to their concerns and make them feel comfortable. Information is fundamental, but behavior change only comes with a change in attitude.” Tune in for a wealth of wisdom and context that includes observations on: What's complicating containment of the Ebola outbreak; Challenges in public health communication in the current social media environment; What grade health authorities should get on their response to the hantavirus outbreak. Mentioned in this episode:Vanderbilt University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

There's a quiet crisis running through IT leadership that nobody names in the meeting: the certainty that you're in over your head, and that any minute now, someone's going to find out. It comes with the job. And for women in tech, there's a second layer underneath.In this episode of The Catalyst, from Softchoice, a World Wide Technology Company, host Katey Teekasingh sits with three women who've lived imposter syndrome from every altitude: an IT director who wasn't the first pick for her role, a five-time CTO who argues the field itself is the problem, and an MIT scientist who built a whole technology field while the engineering world dismissed her work — then won one of its highest honors.Their answers about how to lead through doubt without faking it will reframe what most IT leaders quietly carry.Key takeawaysWhy getting promoted for being the best engineer sets you up to feel like a fraud — and why it's structural, not personalThe second layer of doubt women in tech describe — the “merit, or a box to check?” question that follows them into every roomHow a top scientist reacted to winning one of engineering's highest honors (hint: her first thought was “is this a scam?”)Three different strategies for leading through uncertainty — without pretending it isn't thereGuest credentialsRosalind Picard, ScD — Founder and Director of the Affective Computing Research Group at the MIT Media Lab; co-founder of Empatica and Affectiva; 2026 recipient of the IEEE Medal for Innovations in Healthcare Technology.Meri Williams — Chief Technology Officer at Pleo; five-time CTO across fintech, retail, banking, and biotech; previously scaled the team that built GOV.UK at the UK's Government Digital Service.Julie Szaj — Director of Organizational Change Management at Washington University; 25+ years across education, learning design, and technology leadership.About Our SponsorThis episode is brought to you by HP, in partnership with Softchoice. HP helps organizations shape the future of work with AI-powered solutions across devices, printing, and services. Learn more at https://www.softchoice.com/technology-partners/hpHashtags#TheCatalyst #Softchoice #HP #ITLeadership #ImposterSyndrome #WomenInTech #CTO #DigitalTransformation #MidMarketITShow Notes & ResourcesConnect with our guests:Rosalind Picard — MIT Media Lab Affective Computing Group: media.mit.edu/groups/affective-computingMeri Williams — Pleo: pleo.ioJulie Szaj — Washington University in St. Louis: wustl.eduReferenced in the episode:Affective Computing (1997) by Rosalind Picard — the founding text of the fieldIEEE Medal for Innovations in Healthcare Technology — 2026 recipient: Rosalind PicardEmpatica — wearable health technology co-founded by Picard: empatica.comLearn more about HP's partnership with Softchoice: https://www.softchoice.com/technology-partners/hpThe Catalyst by Softchoice is the podcast dedicated to exploring the intersection of humans and technology. 

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

What if educating your people so well that they could leave was exactly the point? At Your Health, that's not a risk to manage — it's the philosophy that built an entire learning ecosystem. In this episode, Jamie talks with Aubrey Wall, who came to Your Health from a background in education and now leads Your Health University, the organization's learning management system and continuous-development engine. Aubrey brings an educator's eye to a fast-evolving healthcare environment, where best practice changes by the day and meeting patients where they are demands that staff never stop learning. Here's what you'll hear: Why a healthcare company runs 12-month, Department of Labor–registered apprenticeships — including programs in management, value-based care, population health, and hospice aide preparation How gamification is being built into nurse instruction (straight from Aubrey's dissertation research) The difference between Your Health University (your classroom) and the Hub (your resource library) How LinkedIn Learning delivered roughly $4.2 million in CEUs to staff last year Meeting Leah — the new AI assistant that helps employees find exactly the right course If you've ever believed growing your people is a cost rather than the whole point, this conversation will change how you think. Press play, then go ask Leah a question. www.YourHealth.Org

"Do nothing for us without us." According to today's guest Robyn Bussey, that operating principle is the basis for effective community health work. "You don't go into a community and dictate. You go and listen and trust and be a partner," she adds. As you'll learn in this enlightening conversation, Bussey is following that approach in her current work as Just Health Director at the Partnership for Southern Equity, an Atlanta-based nonprofit advancing racial equity and shared prosperity across the South.  On this episode of Raise the Line from Elsevier, Bussey provides illuminating  examples of community-rooted work in South Fulton County and rural Georgia, and explains why community health workers may be the most underutilized asset in addressing health disparities. This wide-ranging interview with host Michael Carrese also explores: Bussey's candid perspective on what happened to the surge of interest in health equity that occurred during COVID; Why life expectancy gains in many Southern states have lagged behind the rest of the country; Her advice to students and early-career clinicians about where they're needed most.   Mentioned in this episode:  Partnership for Southern Equity If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast